Ondrej F.
- Country
- Czechia
- Department
- Fakultni Nemocnice Plzen( #1)
Research Overview
- Efficacy, Safety, and Tolerability of Itepekimab in Non-Cystic Fibrosis Bronchiectasis: A Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease: A Phase III Randomized Controlled Trial
Data & Insights
Has run more than one trial at 8 of 97 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in treating non-cystic fibrosis bronchiectasis, focusing on innovative therapeutic approaches for managing respiratory conditions. Their expertise extends to evaluating novel treatments for chronic respiratory disorders.
- Bronchiectasis Management
- Pulmonary Exacerbations
- Respiratory Immunology
The investigator's work encompasses the evaluation of targeted biological therapies for respiratory conditions, particularly focusing on monoclonal antibody treatments in bronchiectasis.
Immunological Therapeutics
The investigator has developed expertise in immunological interventions, particularly studying the role of interleukin pathways in respiratory diseases. Their work involves assessing innovative biological therapies for chronic respiratory conditions.
- Biological Therapeutics
- Immune System Modulation
- Inflammatory Pathways
Their research focuses on understanding the therapeutic potential of targeted immunological treatments in managing chronic respiratory disorders.
Clinical Assessment
The investigator specializes in evaluating therapeutic efficacy and safety in respiratory medicine. Their expertise includes comprehensive assessment of treatment outcomes in bronchiectasis patients.
- Treatment Safety Evaluation
- Clinical Efficacy Assessment
- Patient Tolerability Studies
Their work involves detailed analysis of treatment responses and safety profiles in respiratory therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.